OTR-AC vs Tri-Heal — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
OTR-AC is the common name for oral high-dose BPC-157 acetate. The peptide sequence (GEPPPGKPADDAGLV) is identical to injectable BPC-157 but is dosed at 2–5 mg orally rather than 250–500 µg subcutaneously to compensate for GI degradation and first-pass metabolism. The oral route p...
Calculate OTR-AC dose →Tri-Heal is a vendor healing peptide blend combining TB-500 (25 mg), BPC-157 (10 mg), and KPV (10 mg) - three peptides with complementary tissue repair and anti-inflammatory mechanisms. TB-500 provides systemic tissue repair and anti-fibrotic activity via actin polymerization and...
Calculate Tri-Heal dose →| Parameter | OTR-AC | Tri-Heal |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Preclinical | Vendor Blend |
| Half-Life | 4–6 hours (estimated, oral) | - |
| Typical Dose | 2–5 mg | - |
| Frequency | Once daily | - |
| Route | Oral | Subcutaneous |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.